Epigenetics of cancer and changes in DNA modification in tumours
Epigenetics of cancer and changes in DNA modification in tumours
Importance of early detection and the ‘Beyond the Shock’ programme
BRCA carrier status as a prognostic factor for prostate cancer
Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy
Role of family history and genetic testing in diagnosis
First line treatment against metastatic breast cancer
Effects of lapatinib and trastuzumab on progression free survival
Decision making in surgical breast cancer treatment
President's overview of ASCO 2012
Increased risk of breast cancer among young women treated with radiation as a child
Costly drugs versus paclitaxel as first line therapy for locally advanced or metastatic breast cancer
EMILIA trial: Trastuzumab emtansine improves progression-free survival in HER2-positive breast cancer